Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …

Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …

In light of increasing access to medicines worldwide due to the availability of generics, it is
important to assess whether medicines add value in the context of the health system. Firstly …

Medicines have made an appreciable contribution to improving health. However, even high-
income countries are struggling to fund new premium-priced medicines. This will grow …

The goal of Universal health coverage (UHC) is to ensure that all people obtain the health
services they need without suffering financial hardship when paying for them [1]. This goal is …

This report, with a focus on sustainable access to new medicines, reviews policies that affect
medicines throughout their lifecycle (‎ from research and development to disinvestment)‎ …

ABSTRACT Universal Health Coverage is key to reach the overall health-related
Sustainable Development Goal, and within this, access to safe, effective, quality, and …

Background Medicines are a major driver of quality, safety, equity, and cost of care in low
and middle-income country health systems. Universal health coverage implementers must …

Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …

Background WHO has set a voluntary target of 80% availability of affordable essential
medicines, including generics, to treat major non-communicable diseases (NCDs), in the …